Skip to search formSkip to main contentSkip to account menu

maltose tetrapalmitate

Known as: D-Glucose, 4-O-alpha-D-glucopyranosyl-, tetrahexadecanoate, maltose tetrapalmitate (MTP) 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1994
Review
1994
  • D. Hayes
  • Hematology/oncology clinics of North America
  • 1994
  • Corpus ID: 23686878
1993
1993
Maltose tetrapalmitate (MTP), a non-toxic synthetic glycolipid analog of lipid A, has been shown to have antitumor activity in… 
1989
1989
The antitumor activity of either cortisone-heparin or cortisone-maltose tetrapalmitate combination or both was tested against two… 
1989
1989
Pathological studies were undertaken in three tumor-host models which were subjected to cortisone based treatments. The first… 
1988
1988
Treatment of human colonic cancer in early stages when the process is still limited to the colonic wall is primarily surgery. We… 
1986
1986
Therapeutic effects of radiotherapy (R), chemotherapy, and maltose tetrapalmitate (MTP) immunotherapy alone and in combinations… 
1984
1984
Chemoimmunotherapy in two animal models for urological cancers was studied. The models were Dunning R3327A prostatic carcinoma… 
1980
1980
The effectivenss of maltose tetrapalmitate (MTP) as an antitumour immune adjuvant was verified by its comparison with other known…